Search
NEWS

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

By A Mystery Man Writer

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

A novel HSP90 inhibitor SL-145 suppresses metastatic triple

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Design, synthesis, and biological evalution of bifunctional

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

New ruthenium-xanthoxylin complex eliminates colorectal cancer

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Pan- and isoform-specific inhibition of Hsp90: Design strategy and

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

PDF) Hsp90 restrains ErbB-2/HER2 signalling by limiting

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive